ReviewJournal of the American Heart Association2018

PCSK9 Inhibitors in Lipid Management of Patients With Diabetes Mellitus and High Cardiovascular Risk: A Review.

Yehuda Handelsman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.